AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionKimelman & Baird, LLC
Latest Disclosed Ownership30,656 shares
Latest Disclosed Value $ 6,667,374
Kimelman & Baird, LLC ownership in 4AB / AbbVie Inc.

On May 13, 2026 - Kimelman & Baird, LLC filed a 13F-HR form disclosing ownership of 30,656 shares of AbbVie Inc. (BG:4AB) valued at $6,667,374 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 30,656 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBVIE COM 00287Y109 30,656 0 0.00 6,667 -4.81 0.5487
2026-02-06 2025-12-31 13F ABBVIE COM 00287Y109 30,656 -414 -1.33 7,005 -2.63 0.5382
2025-11-25 2025-09-30 13F ABBVIE COM 00287Y109 31,070 0 0.00 7,194 24.73 0.5618
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 31,070 0 0.00 5,767 -11.40 0.4696
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 31,070 0 0.00 6,510 17.90 0.5531
2025-02-10 2024-12-31 13F ABBVIE COM 00287Y109 31,070 -2,696 -7.98 5,521 -17.20 0.4388
2024-11-15 2024-09-30 13F ABBVIE COM 00287Y109 33,766 0 0.00 6,668 15.14 0.5320
2024-08-19 2024-06-30 13F ABBVIE COM 00287Y109 33,766 4,477 15.29 5,792 75.54 0.4777
2021-08-17 2021-06-30 13F Abbvie cs 00287Y109 29,289 275 0.95 3,299 50.16 0.2941
2019-12-10 2019-09-30 13F Abbvie cs 00287Y109 29,014 -20 -0.07 2,197 4.07 0.3046
2019-11-22 2019-06-30 13F Abbvie cs 00287Y109 29,034 606 2.13 2,111 -7.86 0.2937
2019-07-02 2019-03-31 13F Abbvie cs 00287Y109 28,428 0 0.00 2,291 -12.59 0.3296
2019-02-15 2018-12-31 13F Abbvie cs 00287Y109 28,428 0 0.00 2,621 -2.53 0.4078
2019-01-30 2018-09-30 13F Abbvie cs 00287Y109 28,428 0 0.00 2,689 2.09 0.3389
2019-01-24 2018-06-30 13F Abbvie cs 00287Y109 28,428 28 0.10 2,634 -4.11 0.3458
2018-03-06 2017-12-31 13F Abbvie cs 00287Y109 28,400 0 0.00 2,747 8.84 0.3905
2018-01-02 2017-09-30 13F Abbvie cs 00287Y109 28,400 0 0.00 2,524 22.58 0.3762
2017-08-22 2017-06-30 13F Abbvie COM 00287Y109 28,400 -100 -0.35 2,059 10.88 0.3120
2017-05-17 2017-03-31 13F AbbVie COM 00287Y109 28,500 0 0.00 1,857 4.03 0.2828
2017-04-10 2016-12-31 13F Abbvie COM 00287Y109 28,500 0 0.00 1,785 -0.67 0.2993
2016-12-13 2016-09-30 13F Abbvie COM 00287Y109 28,500 0 0.00 1,797 1.87 0.3159
2016-08-16 2016-06-30 13F Abbvie COM 00287Y109 28,500 0 0.00 1,764 8.35 0.3224
2016-05-13 2016-03-31 13F Abbvie COM 00287Y109 28,500 0 0.00 1,628 -3.55 0.3041
2016-02-12 2015-12-31 13F Abbvie COM 00287Y109 28,500 0 0.00 1,688 -11.85 0.3174
2015-08-12 2015-06-30 13F Abbvie cs 00287Y109 28,500 -1,902 -6.26 1,915 7.58 0.3266
2015-05-12 2015-03-31 13F Abbvie cs 00287Y109 30,402 0 0.00 1,780 -10.55 0.3246
2015-02-12 2014-12-31 13F Abbvie cs 00287Y109 30,402 302 1.00 1,990 14.43 0.3587
2014-11-13 2014-09-30 13F Abbvie COM 00287Y109 30,100 0 0.00 1,739 2.35 0.3287
2014-08-14 2014-06-30 13F Abbvie cs 00287Y109 30,100 0 0.00 1,699 9.83 0.2990
2014-05-20 2014-03-31 13F Abbvie cs 00287Y109 30,100 0 0.00 1,547 -2.70 0.2885
2014-02-13 2013-12-31 13F Abbvie COM 00287Y109 30,100 1,600 5.61 1,590 24.71 0.3043
2013-11-13 2013-09-30 13F Abbvie COM 00287Y109 28,500 0 0.00 1,275 8.23 0.2547
2013-08-07 2013-06-30 13F Abbvie COM 00287Y109 28,500 28,500 1,178 0.2481
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.